This week I cover another of my meta-research projects, this one on systematic review and meta analysis (SRMA) growth as compared to randomized clinical trial (RCT) growth. Short and to the point - hope you enjoy! I highly recommend checking out the associated graphs - just take a quick peek at some point while listening. Find them on my twitter handle @ebrheum
Entries from October 2020
E69: Publication Trends in SRMAs and RCTs
October 29th, 2020 · Comments
Tags: DefaultTag
E68: SELECT-CHOICE Upadacitinib vs Abatacept in RA
October 15th, 2020 · Comments
Active comparator trial! Always my favorite. Lots of fun topics in this one, including noninferiority trials, crafty endpoints, and PROs. Check it out and let me know what you think! @ebrheum
Tags: DefaultTag
E67: Belimumab in Lupus Nephritis (BLISS-LN)
October 1st, 2020 · Comments
Another day, another lupus trial, another round of endpoint shenanigans. Why does that matter? How big is the benefit from belimumab in SLE nephritis? Will this save lives and prevent ESRD / RRT? I try to tackle these issues this week and (hopefully) avoid getting myself in trouble. Hope you enjoy the episode! Let me know what you think @ebrheum on twitter!
Tags: DefaultTag